Merdad Parsey, CMO at Gilead Sciences, holds 82.85K shares in Gilead Sciences (Ticker: GILD), holds 12.79K shares in Sagimet Biosciences, Inc. Class A (Ticker: SGMT), holds ― shares in ArriVent BioPharma, Inc. (Ticker: AVBP).
Merdad Parsey latest transaction was an Uninformative Buy of $189.20K.
What was Merdad Parsey's most profitable transaction?
Merdad Parsey’s most profitable transaction was an Informative Sell of GILD stock on November 29, 2024. The return on the trade was -19.50%.
What is Merdad Parsey's role in Gilead Sciences?
Merdad Parsey's role in Gilead Sciences is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.